Therapy of acute cadaveric renal allograft rejection with adjunctive antithymocyte globulin

Transplantation
R S FiloS B Leapman

Abstract

A randomized and controlled study was conducted to evaluate the efficacy of adjunctive antithymocyte globulin (ATG) therapy for the treatment of the initial rejection episode in first cadaveric transplants. When compared to the control group (29), which received only standard antirejection treatment (SAT) of steroid pulsing and local irradiation, the adjunctive ATG treatment group (23) demonstrated significantly faster recovery rates (8.9 +/- 4.1 versus 6.9 +/- 3.7 days, P = 0.05, respectively) and better graft survival rates (62 +/- 9% versus 91 +/- 7%, respectively) after the first rejection. ATG treatment did not result in fewer subsequent rejection episodes than SAT but long-term allograft survival rates remained superior to controls for the entire 3-year study period. By avoiding ATG treatment in those patients who never experienced clinical rejection on maintenance immunosuppressive therapy, i.e., nonresponders (23 of 90), complications associated with excessive immunosuppression were minimized. The combined results of the non-responder group of patients and ATG-treated patients resulted in a 1-year patient survival of 97% and graft survival of 86%. These results suggest that the most efficacious use of ATG is therapeutic...Continue Reading

Citations

Feb 15, 2003·International Immunopharmacology·Paolo MontiLorenzo Piemonti
Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·R F HunterA T Huang
May 1, 2002·Transplantation·Maria Pia PistilloGiovanni Battista Ferrara
Nov 1, 1983·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·J H Helderman, P Gailiunas
Apr 1, 1986·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·P T McEneryA Tejani
Sep 1, 1984·Kidney International·T B Strom
Mar 1, 1984·The American Journal of Medicine·A H RookC B Currier
Dec 1, 1989·Transplant International : Official Journal of the European Society for Organ Transplantation·M J DennisR W Blamey
Jan 1, 1982·Immunological Reviews·M F Heyworth
Apr 9, 1998·The Surgical Clinics of North America·M Suthanthiran, T B Strom
Jul 15, 2015·Expert Opinion on Pharmacotherapy·Jamal BamoulidKlemens Budde
Jan 1, 1993·Scandinavian Journal of Rheumatology·A TarkowskiM Aurell
Apr 26, 1990·The New England Journal of Medicine·C B Carpenter
Jul 22, 2017·The Cochrane Database of Systematic Reviews·Angela C WebsterSue J Carr
Jun 9, 1998·Annals of the New York Academy of Sciences·T Chonmaitree, T Heikkinen
Jun 9, 1998·Annals of the New York Academy of Sciences·G S Giebink
Jan 1, 1988·Acta Oto-laryngologica. Supplementum·D J LimL O Bakaletz
May 23, 2000·Annals of Medicine·T Heikkinen, T Chonmaitree
Oct 1, 1996·American Journal of Respiratory and Critical Care Medicine·A HåkanssonC Svanborg
Aug 1, 1996·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·M SuthanthiranT B Strom

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.